Table 2.

Response to Treatment With BTI-322

System CR (%) PR (%)
Skin  7/15 (47) 6/15 (40)  
Liver  0/5 (0)  0/5 (0)  
Gut 4/11 (36)  2/11 (18)  
Overall  6/20 (30) 5/20 (25) 
System CR (%) PR (%)
Skin  7/15 (47) 6/15 (40)  
Liver  0/5 (0)  0/5 (0)  
Gut 4/11 (36)  2/11 (18)  
Overall  6/20 (30) 5/20 (25) 

Assessed on study day 11.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal